Skip to content

The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man

The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01957098
Acronym
M192
Enrollment
14
Registered
2013-10-08
Start date
2006-10-31
Completion date
2007-05-31
Last updated
2013-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Keywords

L-arabinose, D-xylose, sucrose, glucose, insulin, C-peptide, GLP-1

Brief summary

The purpose of this study is to investigate the effect of L-arabinose and D-xylose in a sugar-rich drink on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose and D-xylose.

Detailed description

Based on previous scientific results we hypotesize, that pentoses decreases the demand for insulin in metabolizing a given dose of sucrose.

Interventions

DIETARY_SUPPLEMENTPlacebo comparator: 0% pentose

14 healthy subjects participated in a randomized double-blinded cross-over study based on four single tests. Sucrose containing drinks were supplemented with two different doses of D-xylose and in addition one dose of L-arabinose was included for comparison with earlier studies. Blood was collected fasting and for 3-h postprandially. Appetite sensations and energy intake were registered. Gastrointestinal symptoms were monitored for 24 hours

DIETARY_SUPPLEMENTActive comparator: 4% D-xylose
DIETARY_SUPPLEMENTActive comparator: 8% D-xylose
DIETARY_SUPPLEMENTActive comparator: 8% L-arabinose

Sponsors

Danisco
CollaboratorINDUSTRY
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy males * BMI between 18.4-25 kg/m2 * age between 18 and 30

Exclusion criteria

* donation of blood 3 months before or during the study * gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic infectious disease (HIV or hepatitis) * smoking * consumption of more than 21 alcoholic drinks/week * elite athletes * on medication

Design outcomes

Primary

MeasureTime frameDescription
Blood glucose, insulin, C-peptide and GLP-1-15, 0, 15, 30, 45, 60, 90, 120, 180 minLevel of glucose, insulin, C-peptide and glucagon-like peptide-1 (GLP-1) over time, the area under the curve (AUC), the peak value and time to peak

Secondary

MeasureTime frameDescription
Appetite measurements and energy intake-15, 30, 60, 90, 120, 150 and 180 minAppetite measurements: area under/over the curve (AUC/AOC), 3-h mean. Energy intake: the ad libitum energy intake at lunch was registered. VAS was used to asses the palatability (appearance, smell, taste, after-taste and overall palatability) of the ad libitum lunch.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026